- Home
- TOMZ vs SONN Comparison
TOMZ vs SONN Comparison
Compare TOMZ & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOMZ
- SONN
- Stock Information
- Founded
- TOMZ 1979
- SONN N/A
- Country
- TOMZ United States
- SONN United States
- Employees
- TOMZ N/A
- SONN N/A
- Industry
- TOMZ Diversified Commercial Services
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- TOMZ Finance
- SONN Health Care
- Exchange
- TOMZ Nasdaq
- SONN Nasdaq
- Market Cap
- TOMZ 20.4M
- SONN 21.4M
- IPO Year
- TOMZ N/A
- SONN N/A
- Fundamental
- Price
- TOMZ $0.85
- SONN $5.90
- Analyst Decision
- TOMZ Strong Buy
- SONN Strong Buy
- Analyst Count
- TOMZ 1
- SONN 1
- Target Price
- TOMZ $3.50
- SONN $20.00
- AVG Volume (30 Days)
- TOMZ 26.0K
- SONN 825.4K
- Earning Date
- TOMZ 10-29-2025
- SONN 08-13-2025
- Dividend Yield
- TOMZ N/A
- SONN N/A
- EPS Growth
- TOMZ N/A
- SONN N/A
- EPS
- TOMZ N/A
- SONN N/A
- Revenue
- TOMZ $6,219,036.00
- SONN $1,000,000.00
- Revenue This Year
- TOMZ $18.31
- SONN $5,376.22
- Revenue Next Year
- TOMZ $103.30
- SONN N/A
- P/E Ratio
- TOMZ N/A
- SONN N/A
- Revenue Growth
- TOMZ N/A
- SONN 1689.52
- 52 Week Low
- TOMZ $0.63
- SONN $1.08
- 52 Week High
- TOMZ $1.50
- SONN $19.30
- Technical
- Relative Strength Index (RSI)
- TOMZ 44.48
- SONN 74.18
- Support Level
- TOMZ $0.82
- SONN $2.71
- Resistance Level
- TOMZ $0.92
- SONN $4.35
- Average True Range (ATR)
- TOMZ 0.05
- SONN 0.58
- MACD
- TOMZ 0.00
- SONN 0.22
- Stochastic Oscillator
- TOMZ 29.00
- SONN 80.96
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.